Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth K Ng

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 26, 2002
A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasisRobert J Downey, Kenneth K Ng, Mark G Kris, et al.
Nanoscale|January 6, 2016
Stable J-aggregation enabled dual photoacoustic and fluorescence nanoparticles for intraoperative cancer imagingMojdeh Shakiba, Kenneth K Ng, Elizabeth Huynh, et al.
Cureus|May 6, 2020
U.S. Healthcare Insurance Market Concentration from 2001 to 2016: Increased Growth in Direct Written Premiums and Overall Decreased Market ConsolidationMitchell K Ng, Kenneth K Ng, Simon Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancerNaiyer A Rizvi, Gregory J Riely, Christopher G Azzoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyaninLee M Krug, Govind Ragupathi, Kenneth K Ng, et al.
Journal of Spine Surgery (Hong Kong)|October 15, 2025
Prediction of primary admission total charges following lumbar disc arthroplasty utilizing machine learningPaul G Mastrokostas, Leonidas E Mastrokostas, Ahmed K Emara, et al.
Cancer Chemotherapy and Pharmacology|April 5, 2011
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusionPaul K Paik, Leonard P James, Gregory J Riely, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancerLee M Krug, Christopher G Azzoli, Mark G Kris, et al.
Oral Oncology|September 3, 2025
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinomaLara A Dunn, Alan L Ho, Loren S Michel, et al.
Cell|September 26, 2024
Saturation mutagenesis-reinforced functional assays for disease-related genesKaiyue Ma, Shushu Huang, Kenneth K Ng, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|October 26, 2002
A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasisRobert J Downey, Kenneth K Ng, Mark G Kris, et al.
Nanoscale|January 6, 2016
Stable J-aggregation enabled dual photoacoustic and fluorescence nanoparticles for intraoperative cancer imagingMojdeh Shakiba, Kenneth K Ng, Elizabeth Huynh, et al.
Cureus|May 6, 2020
U.S. Healthcare Insurance Market Concentration from 2001 to 2016: Increased Growth in Direct Written Premiums and Overall Decreased Market ConsolidationMitchell K Ng, Kenneth K Ng, Simon Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancerNaiyer A Rizvi, Gregory J Riely, Christopher G Azzoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyaninLee M Krug, Govind Ragupathi, Kenneth K Ng, et al.
Journal of Spine Surgery (Hong Kong)|October 15, 2025
Prediction of primary admission total charges following lumbar disc arthroplasty utilizing machine learningPaul G Mastrokostas, Leonidas E Mastrokostas, Ahmed K Emara, et al.
Cancer Chemotherapy and Pharmacology|April 5, 2011
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusionPaul K Paik, Leonard P James, Gregory J Riely, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancerLee M Krug, Christopher G Azzoli, Mark G Kris, et al.
Oral Oncology|September 3, 2025
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinomaLara A Dunn, Alan L Ho, Loren S Michel, et al.
Cell|September 26, 2024
Saturation mutagenesis-reinforced functional assays for disease-related genesKaiyue Ma, Shushu Huang, Kenneth K Ng, et al.
Pageof 5